Clinical trials
Acute Coronary Syndrome clinical trials
Below are recruiting acute coronary syndrome clinical trials, each written for real people, not researchers. We’re tracking 205 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06486233Recruiting
Early invasive treatment for elderly heart attack patients
This trial tests whether early invasive treatment (like stenting) is safe and effective for patients 60 or older who have a certain type of heart attack called high-risk non-ST-segment elevation acute coronary syndrome. The goal is to see if this approach improves outcomes for older adults.
Ho Chi Minh CityAges 60 years+ - NCT06543082RecruitingPhase 4
Study on heart attack patients with antiplatelet and colchicine therapy
This trial is for people who had a heart attack and received a specific type of stent (Orsiro). It tests a combination of a single antiplatelet drug and colchicine to see if it helps prevent future heart problems. Colchicine is a medicine that reduces inflammation and might lower the risk of another heart attack.
Seongnam-si, Gyeonggi-doAges 20–90 - NCT06567418Recruiting
Early use of PCSK9i in Chinese heart attack patients
This study looks back at medical records of Chinese patients who had a heart attack or unstable angina. It compares outcomes for those who started a newer cholesterol-lowering shot (Alirocumab, brand name Praluent) plus a statin while in the hospital, versus those who only took a statin pill. The goal is to see if starting the shot early helps improve heart health.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06625463Recruiting
Heart rehab at home with family support after a heart attack
This study tests a heart rehab program you can do at home, with help from your family. If you've had a heart attack in the past year and don't have other major health issues, this program might help you recover and stay healthy.
Sleman, Special Region of YogyakartaAges 18–65 - NCT06637657Recruiting
Optimizing long-term heart disease prevention
This trial tests different ways to manage and reduce the risk of future heart problems in people who have already had a heart attack or a procedure to open blocked heart arteries. The goal is to find the best long-term treatment plan to keep you healthy.
AmsterdamAges 18 years+ - NCT06669884Recruiting
New ECG method to quickly sort chest pain in ER
This study tests a new ECG-based technology that may help doctors more quickly sort out the cause of your chest pain in the emergency room. If you have chest pain that needs checking, this tool could help decide how urgent your care is.
Jinan, ShandongAges 18 years+ - NCT06788431RecruitingEarly Phase 1
Study of IMC-001 to stabilize heart artery plaque
This trial tests an investigational drug, IMC-001, to see if it can make artery plaques in the heart more stable and less likely to cause a heart attack. You may be eligible if you've recently had a heart attack or unstable angina and have a specific type of soft plaque in your arteries.
Nanyang, HenanAges 18–75 - NCT06845826Recruiting
Quick Troponin Test in the ER for Chest Pain
This trial is checking a quick bedside blood test (troponin) for people who come to the emergency room with chest pain. It aims to see if the test can help doctors decide faster if you are having a heart attack.
Leuven, Vlaams-BrabantAges 18–75 - NCT06861582Recruiting
Faster troponin test for chest pain in the ER
This study tests a faster way to measure a heart-muscle protein (troponin) in the emergency room, to see if it can help doctors decide sooner whether your chest pain is from a heart attack. If you are having chest pain that started a few hours ago, you may be able to join.
São PauloAges 18 years+ - NCT07039149Recruiting
Dual antiplatelet therapy for acute coronary syndrome
This trial tests giving two blood-thinning medicines early to people who have had a heart attack or unstable chest pain. Researchers want to see if this approach reduces future heart problems.
AmmanAges 18 years+ - NCT07064109Recruiting
Colchicine for inflammation after heart attack
This trial tests if colchicine, an anti-inflammatory medicine, can help people who recently had a heart attack. It looks for markers in your blood to see who might benefit most.
ShanghaiAges 18–80 - NCT07077057Recruiting
AI tool for heart attack detection
This trial tests an artificial intelligence system that helps doctors quickly identify heart attacks (myocardial infarction) in patients with symptoms like chest pain or shortness of breath. It aims to speed up diagnosis and treatment.
Lugano, Canton TicinoAges 18 years+ - NCT07096973Recruiting
Heart rehab recovery study in Davos
This study looks at how people recover during heart rehabilitation at a clinic in Davos. By tracking your progress, researchers hope to learn what helps people get better.
Davos, Kanton GraubündenAges 18 years+ - NCT07105943Recruiting
Exercise intensity study for heart attack recovery
This trial is testing different ways of doing exercise during cardiac rehab to see which helps people feel better and stay active. It's for people who have had a heart attack or similar event in the last year and are considered low risk.
LeiriaAges 18 years+ - NCT07112820Recruiting
Heart imaging test for chest pain without ST elevation
This trial tests if a heart imaging scan (myocardial perfusion) can help doctors better diagnose heart attacks or other conditions in people who come to the hospital with chest pain but without ST elevation on their ECG. It aims to see if the scan adds valuable information before heart catheterization.
Paris, Ilede FranceAges 18 years+ - NCT07151976Recruiting
Clot removal and imaging study for heart attack patients
This trial uses a special camera (OCT) to look inside the heart's arteries during a heart attack and compares the images with the actual material removed from the clot. It aims to better understand what causes heart attacks and improve future treatments.
Toyoake, Aichi-kenAges 20 years+ - NCT07268859Recruiting
Fan to prevent ticagrelor-related shortness of breath
This study tests whether using a small fan can help reduce the shortness of breath (dyspnea) that some people feel when they first start taking the blood thinner ticagrelor after a heart attack.
Istanbul, AvcılarAges 18–65 - NCT07283809Recruiting
Heart care study for patients with common heart problems
This study is collecting information about people with common heart conditions to help doctors learn how to offer better care. If you have had a heart attack, heart failure, or atrial fibrillation, your experience can help improve treatment for others.
Montevarchi, AREZZOAges 18 years+ - NCT06813339RecruitingEarly Phase 1
Testing a new drug in healthy people and those with heart condition
This trial tests a new medicine called UDP-003 in two groups: healthy volunteers and people who had a heart event (acute coronary syndrome) at least a year ago. The goal is to see if the drug is safe and how the body handles it, which could lead to better treatments for heart disease.
Adelaide, South AustraliaAges 18–79 - NCT07402642Recruiting
Early Education to Lower Heart Attack Risk Factors
This trial tests if personalized education after a heart attack helps patients lower their future risk of heart problems. It focuses on people who had an emergency procedure to open blocked arteries.
Las Palmas de Gran Canaria, Las PalmasAges 18 years+ - NCT07429227Recruiting
Gut health and heart disease: a probiotic study
This trial tests whether natural extracts and probiotics can improve gut health in people who have had a recent heart attack (Acute Coronary Syndrome). It uses special exams to measure changes in gut bacteria.
Peschiera del Garda, VeronaAges 30–70 - NCT07619885RecruitingPhase 1
Testing a New Blood Thinner Called CG-0255 in Healthy People
This study tests how a new blood-thinning medication (CG-0255) works in the body and compares it with Plavix, a common blood thinner. Researchers will measure how much of the drug enters your bloodstream and what effects it has on your blood clotting ability.
Miami, FloridaAges 18–55 - NCT07597031Recruiting
Digital Lifestyle Platform for People Leaving Hospital Rehab
This study tests whether a smartphone or tablet app can help people stay healthy and active after leaving rehabilitation. The app guides you through daily activities and healthy habits to support your recovery at home.
Bern, Canton of BernAges 18 years+ - NCT07208591RecruitingPhase 3
Test of an experimental drug for severe viral lung infection (ARDS)
This study tests an experimental drug (STSA-1002) for people with severe breathing problems caused by a viral infection. It aims to see if the drug can help improve oxygen levels and reduce the need for a breathing machine.
Beijing, Beijing MunicipalityAges 18–85
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for acute coronary syndrome?
- Yes. Clin2 currently lists 205 recruiting acute coronary syndrome studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a acute coronary syndrome trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a acute coronary syndrome trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.